Rapid Novor

Industry: Medical Technology

Client Type: Waterloo AC Clients


Rapid Novor Inc is dedicated to developing unparalleled analytical technologies to drastically change the processes in early stage drug research and development in the bio-pharmaceutical sector. Specializing in the field of mass spectrometry-based proteomics, the Novor team is up for the challenges to solve tough problems such as characterizing antibody proteins. We build bioinformatics software and services that deliver accurate, comprehensive and efficient results and enable the integration for pharmaceutical companies to bring the capabilities in-house.

Key Executives

Bin Ma
President

Mingjie Xie
CEO

Qixin Liu
CTO

Social Media